An 18-year-old female, who had a 2-week complaint of generalized pruritus was referred to our clinic in March 2021. Her blood count showed white blood cells of 1.6 × 109/L, absolute neutrophil count 0.9 × 109/L, hemoglobin 70 g/L, and platelet 15 × 109/L. The diagnosis of aplastic anemia (AA) was established by pancytopenia and hypocellular bone marrow (Fig. 1A). The SMAD3 mutation (NM_005902;exon6;c.803G > A;p.R268H) with 53% variant allele frequency was detected by whole-exome sequencing (WES) and validated by Sanger sequencing. The patient’s parents did not carry the mutation (c.803G > A) (Fig. 1B).
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.